相关实验视频

Updated: Jan 18, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

在炎症性肠道疾病中评估体积

Konstantinos C Mpakogiannis¹, Fotios S Fousekis¹, Viktoria-Efthymia C Mpakogianni²

¹Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece (Konstantinos C. Mpakogiannis, Fotios S. Fousekis, Ioanna Nefeli Mastorogianni, Konstantinos H. Katsanos).

Annals of gastroenterology

|September 12, 2025

概括

炎症性肠病 (IBD) 与的大小变化有关. 克罗恩病中脏体积增加可能表明结果更差,而性结肠炎中脏体积可以表明疾病复发.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
放射学放射学是一门学科.

背景情况:

炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),涉及免疫系统的失调.
脏在全身炎症和免疫反应中起着关键作用.
脏参与IBD可能是次要的其他条件或与疾病直接相关.

研究的目的:

调查IBD和脏体积 (SV) 之间的关联.
探索SV在CD和UC中的临床意义.
评估SV作为IBD监测和治疗反应的潜在指标.

主要方法:

审查关于IBD和脏体积的当前研究.
对CD和UC患者的脏大小变化的分析.
SV与临床结果和治疗反应的相关性.

主要成果:

在CD中,主要观察到增加的SV,并与更差的临床结果有关.
在CD中成功治疗infliximab往往与SV的减少有关.
与CD相比,UC患者通常表现出不变或较小的SV,但减少的SV可能表明肠炎复发.

结论:

调整为体重指数的SV测量,可以作为IBD监测,爆发预测和评估生物治疗反应的潜在指标.
基因数据表明IBD和SV之间的双向因果关系.
进一步研究将SV与IBD联系在一起的致病途径至关重要.

关键词:

克罗恩氏病是什么克罗恩氏病是什么的体积和脏的体积.炎症性肠病是一种炎症性肠病.脊髓脊髓脊髓是一个性结肠炎是一种

更多相关视频

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity

Published on: June 11, 2019

Intravital Microscopy of the Spleen: Quantitative Analysis of Parasite Mobility and Blood Flow

Intravital Microscopy of the Spleen: Quantitative Analysis of Parasite Mobility and Blood Flow

Published on: January 14, 2012

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...